CrossrefInfokarte
Risk prediction for locoregional recurrence in mutant‑negative unresectable stage III non‑small cell lung cancer after concurrent chemoradiotherapy: A retrospective study
Oncology Letters · 2026-10-29 · 32 (6) · 1-9
DOI: 10.3892/ol.2026.15930 ↗Abstract
Kein Abstract verfügbar.
EUVIMED